EGFR and neoplasm: To investigate whether inhibition of osimertinib-tolerant/persister cells by sorafenib could affect tumor growth, we used BEM-4 cells, another mouse clonal cell line expressing mutant EGFR we have generated (Supplementary Fig. 11D).